Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacteriophage Therapy for Morganella Morganii PJI
NCT06814756Phase 2Active, not recruiting
- Sponsor
- University of Calgary
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prosthetic joint infection (PJI), sponsored by University of Calgary. Primary endpoint: Clinical response to phage therapy at 1 year. Started Mar 2025; status: active, not recruiting.
02
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT06814756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06814756.